Adrian P.M. van der Meijden

Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials

Richard Sylvester, Adrian P.M. van der Meijden, Willem Oosterlinck et al. · European Urology · 2006 · 2.9K citations

Individual Patients, Urology, Urologic Cancer Epidemiology +7

Maintenance Bacillus Calmette-Guerin for Ta T1 Bladder Tumors Is Not Associated with Increased Toxicity: Results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial

Adrian P.M. van der Meijden, Richard Sylvester, W. Oosterlinck et al. · European Urology · 2003 · 288 citations

European Organisation, Urology, Maintenance Bacillus Calmette-guerin +8

INTRAVESICAL INSTILLATION OF EPIRUBICIN, BACILLUS CALMETTE-GUERIN AND BACILLUS CALMETTE-GUERIN PLUS ISONIAZID FOR INTERMEDIATE AND HIGH RISK TA, T1 PAPILLARY CARCINOMA OF THE BLADDER: A EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER GENITO-URINARY GROUP RANDOMIZED PHASE III TRIAL

Adrian P.M. van der Meijden, Maurizio Brausi, Victor Zambon et al. · The Journal of Urology · 2001 · 139 citations

EAU Guidelines on the Diagnosis and Treatment of Urothelial Carcinoma in Situ

Adrian P.M. van der Meijden, Richard Sylvester, Willem Oosterlinck et al. · European Urology · 2005 · 122 citations

Urology, Surgical Oncology, Genitourinary Cancer +8

Does Isoniazid Reduce Side Effects of Intravesical Bacillus Calmette-Guerin Therapy in Superficial Bladder Cancer? Interim Results of European Organization for Research and Treatment of Cancer Protocol 30911

P. D. J. Vegt, Adrian P.M. van der Meijden, Richard Sylvester et al. · The Journal of Urology · 1997 · 90 citations